Bio-Rad signs multi-year agreements with Quest
Silicon Valley / San Jose Business Journal - 8:17 AM PDT Tuesday, July 17, 2007
Bio-Rad Laboratories Inc., a maker of life science research and clinical diagnostics products, said Tuesday it signed two multi-year agreements with Quest Diagnostics Inc.
Hercules-based BioRad (AMEX:BIO) did not disclose financial terms of the deal with New Jersey-based Quest (NYSE:DGX).
The agreement calls for Quest to place BioPlex 2200 systems and autoimmune test reagents as well as a Bio-Rad assay used for detecting HIV